Replies to post #3983 on Halozyme Therapeutics Inc (HALO)

[DFRAI]

Halo's enhanze platform ( they signed 4-5 large pharma) is effectively competing with biosimilars from MNTA in a way...
HALO enhanze platform cuts infusion time to minutes...how do you view biosimilar...lets say HUMIRA...that will take significantly longer to infuse

price vs convenience etc...

[DFRAI]

Halo's enhanze platform ( they signed 4-5 large pharma) is effectively competing with biosimilars from MNTA in a way...
HALO enhanze platform cuts infusion time to minutes...how do you view biosimilar...lets say HUMIRA...that will take significantly longer to infuse

price vs convenience etc...